A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period
NCT01264094
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
200
Enrollment
INDUSTRY
Sponsor class
Stopped
Enrollment
Conditions
Chronic Hepatitis B
Interventions
DRUG:
Clevudine
Sponsor
Bukwang Pharmaceutical